Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer.
about
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma.Redox Responsive Hyaluronic Acid Nanogels for Treating RHAMM (CD168) Over-expressive Cancer, both Primary and Metastatic Tumors.Immunohistochemical analysis of RHAMM expression in normal and neoplastic human tissues: a cell cycle protein with distinctive expression in mitotic cells and testicular germ cells.
P2860
Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Receptor for hyaluronic acid-m ...... sitive large cell lung cancer.
@en
type
label
Receptor for hyaluronic acid-m ...... sitive large cell lung cancer.
@en
prefLabel
Receptor for hyaluronic acid-m ...... sitive large cell lung cancer.
@en
P2093
P2860
P1476
Receptor for hyaluronic acid-m ...... sitive large cell lung cancer.
@en
P2093
Florian Augustin
Geoffrey Pomme
Michael Fiegl
Thomas Schmid
William Sterlacci
P2860
P304
P356
10.1136/JCLINPATH-2014-202819
P407
P577
2015-03-02T00:00:00Z